WASHINGTON – United States Trade Representative Katherine Tai today met virtually with Dr. Albert Bourla, Chairman and Chief Executive Officer of Pfizer to discuss increasing vaccine production, global health issues and the proposed waiver to certain provisions of the World Trade Organization’s (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) for the COVID-19 pandemic. The Ambassador expressed her deep sympathy for the people of India and reiterated that the Biden-Harris Administration’s top priority is saving lives and ending the pandemic in the United States and around the world.
The Ambassador emphasized her commitment to working with other WTO members on a global response to the COVID-19 pandemic, including the role of developing countries in any solution that addresses critical gaps in global production and distribution of vaccines. Dr. Bourla shared his views on the vital importance of enhancing global access to the vaccine and how trade policy could help address the challenges of increasing vaccine production and distribution around the world and they agreed to stay in communication going forward.
Tweet from @AmbassadorTai
Tweet from USTRSpox: